Literature DB >> 1854739

Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitors.

M K Jain1, B Z Yu, J Rogers, G N Ranadive, O G Berg.   

Abstract

Interpretation of the kinetics of interfacial catalysis in the scooting mode as developed in the first paper of this series [Berg et al. (1991) Biochemistry 30 (first paper of six in this issue)], was based on the binding equilibrium for a ligand to the catalytic site of phospholipase A2. In this paper, we describe direct methods to determine the value of the Michaelis-Menten constant (KMS) for the substrate, as well as the equilibrium dissociation constants for ligands (KL) such as inhibitors (KI), products (KP), calcium (KCa), and substrate analogues (KS) bound to the catalytic site of phospholipase A2 at the interface. The KL values were obtained by monitoring the susceptibility to alkylation of His-48 at the catalytic site of pig pancreatic PLA2 bound to micellar dispersions of the neutral diluent 2-hexadecyl-sn-glycero-3-phosphocholine. The binding of the enzyme to dispersions of this amphiphile alone had little effect on the inactivation rate. The half-time for inactivation of the enzyme bound to micelles of the neutral diluent depended not only on the nature of the alkylating agent but also on the structure and the mole fraction of other ligands at the interface. The KL values for ligands obtained from the protection studies were in excellent accord with those obtained by monitoring the activation or inhibition of hydrolysis of vesicles of 1,2-dimyristoyl-sn-glycerophosphomethanol. Since only calcium, competitive inhibitors, and substrate analogues protected phospholipase A2 from alkylation, this protocol offered an unequivocal method to discern active-site-directed inhibitors from nonspecific inhibitors of PLA2, such as local anesthetics, phenothiazines, mepacrine, peptides related to lipocortin, 7,7-dimethyleicosadienoic acid, quinacrine, and aristolochic acid, all of which did not have any effect on the kinetics of alkylation nor did they inhibit the catalysis in the scooting mode.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854739     DOI: 10.1021/bi00243a036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.

Authors:  Rob C Oslund; Michael H Gelb
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

2.  Cysteine-less glycosylphosphatidylinositol-specific phospholipase C is inhibited competitively by a thiol reagent: evidence for glyco-mimicry by p-chloromercuriphenylsulphonate.

Authors:  Julie D Stanton; Mohammad B Rashid; Kojo Mensa-Wilmot
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 3.  Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling.

Authors:  Aron B Fisher
Journal:  Arch Biochem Biophys       Date:  2016-12-06       Impact factor: 4.013

4.  Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function.

Authors:  Dawn E Tucker; Moumita Ghosh; Farideh Ghomashchi; Robyn Loper; Saritha Suram; Bonnie St John; Milena Girotti; James G Bollinger; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

Review 5.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

6.  Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytes.

Authors:  Lawrence K Lee; Katherine J Bryant; Romaric Bouveret; Pei-Wen Lei; Anthony P Duff; Stephen J Harrop; Edwin P Huang; Richard P Harvey; Michael H Gelb; Peter P Gray; Paul M Curmi; Anne M Cunningham; W Bret Church; Kieran F Scott
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

7.  A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.

Authors:  Intae Lee; Chandra Dodia; Shampa Chatterjee; John Zagorski; Clementina Mesaros; Ian A Blair; Sheldon I Feinstein; Mahendra Jain; Aron B Fisher
Journal:  J Pharmacol Exp Ther       Date:  2013-03-08       Impact factor: 4.030

8.  Surface dilution kinetics of phospholipase A(2) catalyzed lipid-bilayer hydrolysis.

Authors:  Jasmeet Singh; Radha Ranganathan
Journal:  J Phys Chem B       Date:  2014-02-11       Impact factor: 2.991

9.  Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.

Authors:  E C Landucci; E Antunes; J L Donato; R Faro; S Hyslop; S Marangoni; B Oliveira; G Cirino; G de Nucci
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1.

Authors:  Christine Almunia; Marie Bretaudeau; Gerhard Held; Aurélie Babon; Charles Marchetti; Florence Anne Castelli; André Ménez; Bernard Maillere; Daniel Gillet
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.